These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 11400179)
1. Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Callier S; Morissette M; Grandbois M; Pélaprat D; Di Paolo T Synapse; 2001 Aug; 41(2):131-8. PubMed ID: 11400179 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice. D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368 [TBL] [Abstract][Full Text] [Related]
3. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Jourdain S; Morissette M; Morin N; Di Paolo T J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487 [TBL] [Abstract][Full Text] [Related]
4. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760 [TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
7. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease. Al-Sweidi S; Morissette M; Bourque M; Di Paolo T Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296 [TBL] [Abstract][Full Text] [Related]
8. Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice. Callier S; Morissette M; Grandbois M; Di Paolo T Synapse; 2000 Sep; 37(4):245-51. PubMed ID: 10891861 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Schmidt N; Ferger B Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221 [TBL] [Abstract][Full Text] [Related]
10. Regulation of striatal preproenkephalin mRNA levels in MPTP-lesioned mice treated with estradiol. D'Astous M; Morissette M; Callier S; Di Paolo T J Neurosci Res; 2005 Apr; 80(1):138-44. PubMed ID: 15723346 [TBL] [Abstract][Full Text] [Related]
11. Implication of the phosphatidylinositol-3 kinase/protein kinase B signaling pathway in the neuroprotective effect of estradiol in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. D'Astous M; Mendez P; Morissette M; Garcia-Segura LM; Di Paolo T Mol Pharmacol; 2006 Apr; 69(4):1492-8. PubMed ID: 16434614 [TBL] [Abstract][Full Text] [Related]
12. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381 [TBL] [Abstract][Full Text] [Related]
13. Amiloride is neuroprotective in an MPTP model of Parkinson's disease. Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547 [TBL] [Abstract][Full Text] [Related]
14. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Kilbourn MR; Kuszpit K; Sherman P Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034 [TBL] [Abstract][Full Text] [Related]
15. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835 [TBL] [Abstract][Full Text] [Related]
16. Lack of effect of testosterone and dihydrotestosterone compared to 17beta-oestradiol in 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine-mice. Ekue A; Boulanger JF; Morissette M; Di Paolo T J Neuroendocrinol; 2002 Sep; 14(9):731-6. PubMed ID: 12213134 [TBL] [Abstract][Full Text] [Related]
17. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum. Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001 [TBL] [Abstract][Full Text] [Related]
18. Selective alterations of gene expression in mice induced by MPTP. Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605 [TBL] [Abstract][Full Text] [Related]
19. Effect of oestrogen receptors on brain NMDA receptors of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice. Al-Sweidi S; Morissette M; Di Paolo T J Neuroendocrinol; 2012 Nov; 24(11):1375-85. PubMed ID: 22672467 [TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]